Eastgate Biotech Corp
CIK 0001099574
Revenue (TTM)
—
Q3 Feb 2019
Net Income (TTM)
−$3.77M
+30.5% YoY
Q3 Feb 2019
EPS Diluted (TTM)
—
Q3 Feb 2019
Gross Margin
—
Q3 Feb 2019
Operating Margin
—
Q3 Feb 2019
Net Margin
—
Q3 Feb 2019
Free Cash Flow (TTM)
−$812.48K
Q3 Feb 2019
Cash
$0
Q3 Feb 2019
Total Debt
—
Q3 Feb 2019
Shares Outstanding
2.06B sh
Q3 Feb 2019
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.